Document is current
Any future updates will be listed below
-
Authors
Musunuru, Kiran https://orcid.org/0000-0003-3298-0368
Chadwick, Alexandra C.
Mizoguchi, Taiji
Garcia, Sara P. https://orcid.org/0000-0003-3312-6454
DeNizio, Jamie E.
Reiss, Caroline W. https://orcid.org/0000-0002-6385-1879
Wang, Kui
Iyer, Sowmya
Dutta, Chaitali
Clendaniel, Victoria https://orcid.org/0000-0002-2969-4443
Amaonye, Michael https://orcid.org/0000-0001-6683-2545
Beach, Aaron
Berth, Kathleen
Biswas, Souvik
Braun, Maurine C.
Chen, Huei-Mei
Colace, Thomas V.
Ganey, John D.
Gangopadhyay, Soumyashree A.
Garrity, Ryan https://orcid.org/0000-0002-5015-4505
Kasiewicz, Lisa N.
Lavoie, Jennifer
Madsen, James A.
Matsumoto, Yuri
Mazzola, Anne Marie
Nasrullah, Yusuf S.
Nneji, Joseph
Ren, Huilan
Sanjeev, Athul https://orcid.org/0000-0003-4089-5315
Shay, Madeleine
Stahley, Mary R.
Fan, Steven H. Y.
Tam, Ying K.
Gaudelli, Nicole M. https://orcid.org/0000-0001-8608-4855
Ciaramella, Giuseppe
Stolz, Leslie E.
Malyala, Padma
Cheng, Christopher J.
Rajeev, Kallanthottathil G.
Rohde, Ellen
Bellinger, Andrew M.
Kathiresan, Sekar https://orcid.org/0000-0002-3711-7101
- License Information
-
More Information
Article History
Received: 6 December 2020
Accepted: 11 April 2021
First Online: 19 May 2021
Competing interests
: K.M. is an advisor to and holds equity in Verve Therapeutics and Variant Bio. A.M.B. is an employee of Verve Therapeutics and holds equity in Verve Therapeutics, Lyndra Therapeutics, Corner Therapeutics and Cocoon Biotech. S.K. is an employee of Verve Therapeutics, holds equity in Verve Therapeutics and Maze Therapeutics, and has served as a consultant for Acceleron, Eli Lilly, Novartis, Merck, Novo Nordisk, Novo Ventures, Ionis, Alnylam, Aegerion, Haug Partners, Noble Insights, Leerink Partners, Bayer Healthcare, Illumina, Color Genomics, MedGenome, Quest and Medscape. S.H.Y.F. and Y.K.T. are employees of and hold equity in Acuitas Therapeutics. N.M.G. and G.C. are employees of and hold equity in Beam Therapeutics. All other authors are employees of and hold equity in Verve Therapeutics. Verve Therapeutics has filed for patent protection related to various aspects of therapeutic base editing of <i>PCSK9</i>, with A.C.C., C.J.C., C.W.R., K.G.R. and E.R. as the inventors.
